Amoxicillin–clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial

BACKGROUND: Although amoxicillin–clavulanate is the recommended first-line empirical oral antibiotic treatment for non-severe exacerbations in children with bronchiectasis, azithromycin is also often prescribed for its convenient once-daily dosing. No randomised controlled trials involving acute exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Vikas, Grimwood, Keith, Byrnes, Catherine A, Morris, Peter S, Masters, I Brent, Ware, Robert S, McCallum, Gabrielle B, Binks, Michael J, Marchant, Julie M, van Asperen, Peter, O'Grady, Kerry-Ann F, Champion, Anita, Buntain, Helen M, Petsky, Helen, Torzillo, Paul J, Chang, Anne B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159066/
https://www.ncbi.nlm.nih.gov/pubmed/30241722
http://dx.doi.org/10.1016/S0140-6736(18)31723-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159066/
https://www.ncbi.nlm.nih.gov/pubmed/30241722
http://dx.doi.org/10.1016/S0140-6736(18)31723-9

Ejemplares similares